Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in Danville, IN
NPI: 1316994148Primary Practice Location
HENDRICKS REGIONAL HEALTH
5492 N Ronald Reagan Pkwy, Brownsburg, IN
Primary Employer
Hendricks Oncology
hendricks.org
HQ Phone
Get M.D. Sridhar's Phone Numberphone_androidMobile
Get M.D. Sridhar's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
IN State Medical License
2004 - 2025
NY State Medical License
2001 - 2004
OH State Medical License
1998 - 2001
National Board of Physicians and Surgeons
Hematology
National Board of Physicians and Surgeons
Medical Oncology
Brooklyn Hospital Center
Fellowship • Hematology and Medical Oncology
2001 - 2004
Residency • Internal Medicine
1995 - 1998
Sri Ramachandra Medical College
Medical School
Until 1992
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 434 | 991 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 392 | 503 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 196 | 196 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 59 | 59 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 49 | 53 |
HELLP syndrome leading to a diagnosis of pregnancy.
Authors: Satheesh K. Kathula, Sridhar R. Bolla, Everett F. Magann
Publication Date: 2002-08
Authors: de Leon, Maria C B, Bolla, Sridhar, Greene, Barbra, Hutchinson, Lauren, Del Priore, Giuseppe
Journal: Gynecol Oncol Case Rep
Publication Date: 2013-05-14
Lead Sponsor: Stemline Therapeutics, Inc.
Intervention / Treatment: DRUG: Standard of Care, DRUG: Elacestrant
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Intervention / Treatment: DRUG: Placebo, DRUG: Carboplatin, DRUG: Cisplatin, DRUG: Paclitaxel, DRUG: Etoposide, DRUG: Pemetrexed, DRUG: Durvalumab, RADIATION: Intensity Modulated Radiation Therapy (IMRT), DRUG: M7824
Lead Sponsor: Odonate Therapeutics, Inc.
Intervention / Treatment: DRUG: Capecitabine, DRUG: Tesetaxel and Capecitabine
